I

Ipsen Global

Global biopharma focused on specialty care

Senior Manager - Global Late-Stage Partnering, Business Development

Corporate StrategyConfirmed live in the last 24 hours
Full-timeCambridge, MA, USAIn-person

About the Job

Requirements

  • A bachelor's or master's degree in a scientific, medical, or business discipline is required.
  • Three to seven years of experience in business development, competitive intelligence, corporate strategy, management consulting, equity research, portfolio strategy, or the biopharmaceutical industry.
  • A strong understanding of the pharmaceutical and biotechnology industry, including drug development, regulatory pathways, commercialization, and business development.
  • The ability to evaluate scientific, clinical, commercial, competitive, and strategic dimensions of external opportunities.
  • The ability to synthesize large volumes of information into clear, actionable insights and maintain attention to detail while taking an enterprise-wide perspective.
  • The ability to identify emerging trends and anticipate events that could influence partnering strategy and priorities.
  • The ability to establish credibility, work effectively with stakeholders across multiple functions and organizational levels, coordinate cross-functional input, and drive alignment around assessments and recommendations.
  • The ability to communicate complex information effectively to senior executives and governance bodies, including developing Board-level materials.
  • The ability to influence without direct authority and operate effectively in a highly matrixed global organization.

Responsibilities

  • Lead and maintain Ipsen’s Late-Stage Opportunity Intelligence process across Oncology, Rare Diseases, and Neuroscience, developing a comprehensive view of the external partnering landscape and identifying and prioritizing potential business development opportunities.
  • Coordinate insights from stakeholders across Research and Development, Medical Affairs, Commercial, Finance, and Legal to assess the strategic fit and attractiveness of external programs and companies.
  • Translate scientific, clinical, commercial, and competitive information into actionable insights, strategic analyses, and executive-level recommendations to support portfolio planning and partnering decisions.
  • Own and maintain a comprehensive, continuously updated landscape of late-stage partnering opportunities across Oncology, Rare Diseases, and Neuroscience.
  • Develop and manage a systematic process for identifying, tracking, evaluating, and prioritizing external assets and companies of strategic interest.
  • Monitor the external environment for emerging opportunities, competitive developments, strategic transactions, and market-dynamic shifts that may affect business development priorities.
  • Establish and maintain tools, databases, dashboards, and reporting mechanisms that provide visibility into the external opportunity universe.
  • Serve as the internal owner of the external opportunity universe and keep opportunity assessments current, organized, and actionable.
  • Track, analyze, and maintain a forward-looking view of key clinical, regulatory, commercial, corporate, and financing milestones for programs and companies of strategic interest.
  • Communicate important developments and their potential implications to the Global Late-Stage Partnering team and relevant internal stakeholders.
  • Build and maintain working relationships with leaders and subject matter experts across Oncology, Rare Diseases, and Neuroscience.
  • Coordinate the gathering, consolidation, and maintenance of Ipsen’s perspectives on externally monitored assets and companies.
  • Maintain institutional knowledge of previous opportunity evaluations and strategic discussions.
  • Provide ad hoc support on selected late-stage business development transactions, including opportunity assessments, diligence preparation, competitive analyses, valuation support, and internal decision-making materials.
  • Participate in transaction teams as appropriate, supporting evaluation and execution of strategic licensing, acquisition, and collaboration opportunities; maintain a primary focus on identifying, monitoring, prioritizing, and strategically assessing external partnering opportunities.

Desired Qualifications

  • Experience evaluating external assets, technologies, or pipeline opportunities is highly desirable.
  • An advanced scientific degree (PhD, PharmD, or MD) and/or an MBA is preferred.

About the Company

Ipsen Global

Global biopharma focused on specialty care

Ipsen is a global biopharmaceutical company that concentrates on specialty care, developing and marketing medicines for oncology, neuroscience, and rare diseases. Its products work by treating specific high-need conditions, ranging from historical diarrhea treatment Smecta to modern targeted therapies in cancer and neurological disorders. The company differentiates itself through a focused portfolio in niche therapeutic areas, growth via strategic acquisitions, and a long-standing family heritage that shaped its international expansion and IPO-driven capital for expansion. Its goal is to address unmet medical needs worldwide by providing effective therapies for patients with serious or rare conditions.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boulogne-Billancourt, France
Founded
2005

Recently Posted Jobs

Explore more opportunities at Ipsen Global

See more jobs